By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Panelists agree that SpaceX's high capex and ambitious targets pose significant execution and geopolitical risks, but they differ on the extent to which these risks are priced into the current valuation.
Risk: Geopolitical friction, regulatory hurdles, and the risk of competitors capping SpaceX's margins and undermining its $1T revenue narrative.
Opportunity: The potential for SpaceX to execute on its $100B revenue run rate by 2026 and $1T by 2030, given its strong Q2 performance and long-term targets.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
If history is any helpful guide, then SpaceX (SPCX) shares haven't bottomed yet.
Looking at major IPOs over the past 15 years, 19 of the 31 (61%) saw a maximum drawdown of more than 50% in their first year of trading, per Truist chief markets strategist Keith Lerner. The largest first-year drop belongs to Robinhood (HOOD), with a decline of 90%.
SpaceX is already worse relative to the averages.
The stock finished its first week down 4% and its first month off by 16%, both severe underperformance versus the average for each period. The max drawdown on the stock so far this year has amounted to 46%, better than the average decline of 55%.
SpaceX did its part in sparking this debate today.
The stock is down 10% in Wednesday. It's now trading around $116, light-years removed from the record high of about $225. Investors were rattled by SpaceX's planned capital expenditures in its first earnings report late Tuesday.
The harsh reaction is similar to the one incurred by Alphabet (GOOG, GOOGL), whose stock plunged after reporting that big-time money will be spent on advancing AI initiatives.
Total capital expenditures for SpaceX in the second quarter were $18.4 billion, well above analyst estimates of around $6 billion. Commentary by executives indicated that third and fourth quarter capex could each remain at similar levels, implying full-year capex of about $65 billion. Wall Street was modeling for $50 billion capex this year.
Execs did share several long-term targets, however, including a $100 billion revenue run rate by the end of 2026. It also projected $1 trillion in revenue in 2030.
"Prior to the IPO, the financial projections we had were reaching $1 trillion in revenue in 2031. We now expect that to be in 2030. There's a non-zero chance of that being in 2029," SpaceX and Tesla CEO Elon Musk said on the earnings call.
The aggressive capex and lack of guidance overshadowed SpaceX beating estimates out of the box.
Second quarter revenue of $7.8 billion came in above the Street's $6.8 billion estimate. EBITDA of $3.5 billion also exceeded the Street's $2.1 billion estimate. The beats were driven primarily by AI segment revenue, as SpaceX contracted about $14 billion of cloud services agreements in the quarter.
"I think it's pretty difficult to call something a generational opportunity that's trading at 77 times sales right now. Starship had 12 or 13 test flights. And that seems to be moving at pace. But it's a money burner," said B. Riley chief markets strategist Art Hogan on Yahoo Finance's Opening Bid.
Four leading AI models discuss this article
"SpaceX's aggressive capex is an investment in accelerating its own long-term guidance, not a red flag, making the current 46% drawdown a buying opportunity rather than the start of a 50-90% collapse."
The article's historical analogy to post-IPO drawdowns is flawed because SpaceX is not a typical tech IPO. Its $18.4B Q2 capex (far above $6B estimates) funds Starship, Starlink expansion, and AI/cloud infrastructure that drove a $14B contract win, beating revenue ($7.8B vs $6.8B) and EBITDA ($3.5B vs $2.1B). Musk's accelerated guidance to $100B revenue run-rate by end-2026 and $1T by 2030 (potentially 2029) implies the current ~77x sales multiple could compress rapidly if execution holds. The 46% drawdown from $225 to $116 already prices in much of the capex shock; history of HOOD-style 90% drops is irrelevant for a vertically integrated aerospace/AI leader with government contracts and real revenue inflection.
If Starship test flights continue to slip and capex stays at $65B+ annually while AI/cloud competition from hyperscalers intensifies, the path to $1T revenue could stretch beyond 2030, leaving the stock vulnerable to further 30-50% downside as cash burn accelerates and multiples rerate lower.
"The market is incorrectly punishing SpaceX for high capex that is actually pre-funding a dominant, high-margin cloud and logistics infrastructure monopoly."
The market is mispricing SpaceX by treating it as a traditional aerospace firm rather than a diversified infrastructure and AI play. While the $18.4 billion quarterly capex is jarring, it reflects an aggressive land-grab in orbital cloud services and Starship deployment. Trading at 77x sales is undeniably steep, but the $14 billion in new cloud contracts proves the 'AI segment' is not just hype—it’s a revenue engine. The 46% drawdown is a classic volatility trap for retail investors who lack the conviction to hold through the heavy investment phase. If SpaceX executes on its $100 billion revenue run rate by 2026, today’s valuation will look like a bargain for a generational monopoly.
The strongest counter-argument is that SpaceX is burning cash at a rate that ignores the cost of capital, making it hyper-sensitive to interest rate hikes that could force a massive, dilutive equity raise if the cloud segment growth stalls.
"SpaceX's 77x sales multiple requires flawless execution on a $1T revenue target by 2030; the capex surprise reveals either management credibility issues or analyst incompetence, but either way, the stock has priced in success, not risk."
The article conflates two separate problems: IPO volatility patterns (which are real but backward-looking) and SpaceX's specific capex shock (which is forward-looking and material). Yes, 61% of IPOs see >50% drawdowns—but that's noise if the underlying business justifies the spend. SpaceX beat Q2 revenue and EBITDA handily; the capex miss ($18.4B vs. $6B estimate) signals either analyst blindness or management miscommunication pre-earnings. The $65B full-year capex against a $100B revenue run-rate target by end-2026 implies negative FCF near-term but potentially massive operating leverage if Starship/Starlink scale. The real risk: execution risk on $1T revenue by 2030 (a 128x current revenue target in 5 years) is being priced as certainty, not optionality. At 77x sales, you're paying for perfection.
If Starship succeeds and Starlink captures even 20% of the $1T addressable market (satellite comms + space infrastructure), the capex is a bargain and the stock reprices 3-5x within 24 months—the article's historical IPO comparison becomes irrelevant noise.
"Long-run upside hinges on monetizing Starship and Starlink and sustaining defense contracts; near-term weakness may be a quality entry point if milestones land."
Bearish near term, but not a doom loop. The article flags a brutal initial trading pattern and outsized capex (Q2 capex $18.4B vs estimates $6B; full-year around $65B vs $50B). It relies on IPO analogies to argue for more drawdown. Yet it glosses on SpaceX’s stated long-run targets—$100B revenue by 2026 and $1T by 2030—tied to Starship, Starlink, and defense work. If those programs hit milestones and capex cools after ramp, a re-rating is plausible. The key risk is non-linear execution, policy shifts, or delays; valuation remains highly contingent on milestones rather than visible cash-flow generation today.
The strongest counter is that even with big long-run targets, near-term cash burn and uncertain Cadence of Starship/Starlink monetization could push the stock lower for years; a few missed milestones could erase the expected rerating.
"Geopolitical and regulatory veto points on Starlink/Starship contracts represent an unmentioned tail risk that could stall revenue inflection far longer than execution slippage alone."
Claude correctly flags execution risk at 77x sales, yet all four underplay regulatory and geopolitical friction. Starlink's $14B contracts hinge on DoD/foreign approvals that can evaporate with one policy shift or spectrum dispute. If capex stays elevated amid export controls on Starship tech, the path to $100B run-rate by 2026 lengthens dramatically, exposing the multiple to a sharper rerating than any IPO analogy suggests.
"The 'monopoly' narrative creates an existential political risk that will force the government to manufacture competition, destroying SpaceX's long-term margin profile."
Gemini’s 'generational monopoly' thesis ignores the brutal reality of orbital congestion and spectrum sovereignty. Grok is right about geopolitical friction, but misses the deeper risk: SpaceX is building a 'company-state' model that invites antitrust scrutiny far beyond standard tech. If the DoD realizes they are effectively hostage to a single private entity for critical infrastructure, they will subsidize competitors like Blue Origin or Rocket Lab, permanently capping SpaceX’s margins and undermining the $1T revenue narrative.
"DoD competition doesn't protect SpaceX's margins—it erodes them by fragmenting the orbital market and validating alternatives to SpaceX's monopoly pricing."
Gemini's antitrust concern is real but inverts the actual risk. DoD subsidizing competitors doesn't cap SpaceX margins—it validates the orbital infrastructure market and fragments it, lowering SpaceX's addressable total. The deeper issue: SpaceX's $1T thesis assumes monopoly pricing power. If Blue Origin, Rocket Lab, or foreign competitors scale, SpaceX's capex burn becomes a liability, not an asset. Grok and Gemini both flag geopolitical friction correctly, but neither quantifies how export controls on Starship tech could force a 2-3 year delay in the $100B run-rate target.
"Timing risk from a multi-year cadence miss could push the $100B target beyond 2026, keeping capex high and multiples compressed."
Claude’s export-control delay scenario, while plausible, overstates the certainty and underweights domestic versus international demand. Starship controls could slow overseas sales, but DoD and US customers likely cushion timing; the bigger risk is a multi-year cadence miss that pushes the $100B target beyond 2026, keeping capex high and multiples compressed even if Starlink scales. In short: timing risk, not a clean rerate, is the real bear case to model.
Panelists agree that SpaceX's high capex and ambitious targets pose significant execution and geopolitical risks, but they differ on the extent to which these risks are priced into the current valuation.
The potential for SpaceX to execute on its $100B revenue run rate by 2026 and $1T by 2030, given its strong Q2 performance and long-term targets.
Geopolitical friction, regulatory hurdles, and the risk of competitors capping SpaceX's margins and undermining its $1T revenue narrative.